However, the basic step for this personalized approach includes the precise characterization of the individual tumor regarding the receptor tyrosine kinase (RTK) pattern—both the expression and phosphorylation correlating with activation—as well as of downstream signaling pathways. The gene discussed is NTRK1; the disease is neoplasm.